Phase I trial of etoposide, doxorubicin and cisplatin (EAP) in combination with GM-CSF
- 30 April 1996
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (4), 631-635
- https://doi.org/10.1016/0959-8049(95)00602-8
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating FactorNew England Journal of Medicine, 1992
- Cancer statistics, 1992CA: A Cancer Journal for Clinicians, 1992
- Effects of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Myelosuppression induced by Multiple Cycles of High-Dose Chemotherapy in Patients With Advanced Breast CancerJNCI Journal of the National Cancer Institute, 1991
- Phase II Trial of Etoposide (V), Adriamycin (A), and Cisplatinum (P) in Patients with Metastatic Gastric CancerAmerican Journal of Clinical Oncology, 1991
- Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma.Journal of Clinical Oncology, 1990
- Escalated Therapy for Refractory Urothelial Tumors: Methotrexate- Vinblastine-Doxorubicin- Cisplatin Plus Unglycosylated Recombinant Human Granulocyte-macrophage Colony-Stimulating FactorJNCI Journal of the National Cancer Institute, 1990
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow TransplantationNew England Journal of Medicine, 1988
- Effects of GM‐CSF deprivation on precursors of granulocytes and macrophagesJournal of Cellular Physiology, 1982
- Clonal analysis of progenitor cell commitment to granulocyte or macrophage productionJournal of Cellular Physiology, 1982
- 5-Fluorouracil, Doxorubicin, and Mitomycin (FAM) Combination Chemotherapy for Advanced Gastric CancerAnnals of Internal Medicine, 1980